V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250007473 | 250005239 | null | null | null | 2013-03-22 | 2013-03-22 | RUXOLITINIB | 2 | N | 250032147 | FCR |
| 250007474 | 250009747 | null | null | Adjuvant (A) | 2015-05-25 | 2015-05-25 | Azacitidine | null | N | 250032150 | AML16 TRIAL |
| 250007475 | 250005240 | null | null | Palliative (P) | 2013-01-09 | 2013-01-16 | BUSULFAN | 02 | N | 250032156 | IMATINIB |
| 250007476 | 250009748 | 1.74 | null | Disease modification (D) | null | 2014-11-12 | Azacitidine | N | N | 250032159 | RUXOLITINIB |
| 250007477 | 250005241 | null | null | Not known (9) | 2017-04-26 | 2017-04-26 | RUXOLITINIB | N | N | 250032160 | RUXOLITINIB |
| 250007478 | 250005241 | 1.74 | null | Palliative (P) | 2014-10-28 | 2014-11-11 | Imatinib 400mg | 02 | N | 250032160 | RUXOLITINIB |
| 250007479 | 250005241 | 1.76 | 100 | Disease modification (D) | 2014-03-14 | 2014-04-11 | THALIDOMIDE | N | N | 250032160 | RUXOLITINIB |
| 250007481 | 250005243 | 0 | 71.1 | Curative (C) | 2014-10-02 | 2014-10-18 | ATG + Busulfan + Fludarabine | Y | N | 250032165 | RUXOLITINIB |
| 250007482 | 250009750 | 0 | 0 | Palliative (P) | 2015-08-10 | 2015-08-26 | CVP R | N | N | 250032166 | FCR |
| 250007483 | 250005244 | null | 73 | Curative (C) | 2018-09-30 | 2018-09-30 | RUXOLITINIB | N | N | 250032167 | RUXOLITINIB |
| 250007484 | 250005245 | null | 0 | Palliative (P) | 2017-05-14 | 2017-05-14 | Rituximab | 1 | N | 250032169 | BUSULPHAN |
| 250007485 | 250005246 | 0 | 73.8 | Curative (C) | 2017-05-28 | 2017-06-03 | BUSULFAN | N | N | 250032177 | RUXOLITINIB |
| 250007486 | 250005247 | null | null | null | 2014-12-20 | 2014-12-20 | Pazopanib | N | N | 250032180 | CYTARABINE |
| 250007487 | 250005248 | 1.67 | 64.2 | Curative (C) | 2017-08-27 | 2017-08-27 | ANAGRELIDE | 02 | null | 250032183 | RUXOLITINIB |
| 250007488 | 250005249 | 1.66 | 95.5 | Not known (9) | 2013-03-08 | 2013-03-21 | RUXOLITINIB | 02 | N | 250032186 | RUXOLITINIB |
| 250007489 | 250005249 | 1.59 | null | Disease modification (D) | 2015-08-04 | 2015-08-15 | RUXOLITINIB | N | null | 250032186 | PEG INTERFERON |
| 250007490 | 250011620 | 1.67 | 50.6 | Disease modification (D) | 2016-02-26 | 2016-02-26 | RUXOLITINIB | 1 | null | 250032189 | RITUXIMAB |
| 250007491 | 250011620 | 1.73 | 92 | Palliative (P) | 2013-08-02 | 2013-08-02 | AML18 PILOT TRIAL | N | null | 250032189 | TRIAL |
| 250007492 | 250011620 | 0 | 91.5 | Palliative (P) | 2014-12-22 | 2014-12-26 | CHOP R - 21 days | N | N | 250032189 | RUXOLITINIB |
| 250007493 | 250011620 | null | null | Not known (9) | 2018-05-13 | 2018-05-31 | CVP R | 01 | null | 250032189 | RUXOLITINIB |
| 250007494 | 250005250 | null | 66.2 | Curative (C) | null | 2018-06-12 | IMATINIB | null | N | 250032195 | RUXOLITINIB |
| 250007500 | 250005252 | 1.6 | 66.5 | Adjuvant (A) | 2013-08-31 | 2017-04-02 | RUXOLITINIB | N | N | 250032214 | RUXOLITINIB |
| 250007501 | 250005253 | null | 0 | Adjuvant (A) | null | 2015-03-13 | Carboplatin + Paclitaxel (3 weekly) | 99 | N | 250032220 | AZACITIDINE |
| 250007502 | 250005254 | 1.57 | null | Palliative (P) | 2014-03-05 | 2014-03-05 | Not Chemo + Hydroxocobalamin | N | N | 250032225 | CARBOPLATIN + PACLITAXEL |
| 250007503 | 250005255 | null | 65.5 | Palliative (P) | 2014-04-10 | 2014-04-10 | Azacitidine | N | N | 250032231 | RUXOLITINIB |
| 250007504 | 250005255 | 0 | 0 | Palliative (P) | 2015-06-09 | 2015-07-20 | Azacitidine | N | N | 250032231 | BENDAMUSTINE + RITUXIMAB |
| 250007505 | 250011622 | 1.52 | 64 | Disease modification (D) | 2016-07-21 | 2016-07-21 | RUXOLITINIB | N | N | 250032236 | ANAGRELIDE |
| 250007506 | 250011622 | null | 63.7 | Curative (C) | 2017-05-30 | 2017-05-30 | RUXOLITINIB | null | N | 250032236 | RITUXIMAB |
| 250007507 | 250011622 | 0 | 64.9 | null | 2014-11-10 | 2014-11-20 | RUXOLITINIB | 2 | N | 250032236 | TRIAL |
| 250007508 | 250005256 | 1.62 | 84.4 | Palliative (P) | null | 2017-04-30 | ANAGRELIDE | N | null | 250032242 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 250007509 | 250005257 | null | 68.4 | Palliative (P) | 2016-08-29 | 2016-08-29 | RUXOLITINIB | 02 | N | 250032243 | AZACITIDINE |
| 250007510 | 250005258 | 1.74 | 63.6 | Palliative (P) | 2015-12-17 | 2015-12-28 | CHOP R - 21 days | N | N | 250032248 | CHOP R |
| 250007511 | 250005258 | 0 | 89.5 | Palliative (P) | 2015-05-20 | 2015-05-20 | PEG INTERFERON | 2 | N | 250032248 | DASATINIB |
| 250007512 | 250005259 | 1.61 | null | null | 2014-07-28 | 2014-07-28 | PEG INTERFERON | 01 | null | 250032252 | MELPHALAN |
| 250007513 | 250005260 | null | null | Palliative (P) | null | 2016-05-24 | BORTEZOMIB + THALIDOMIDE | null | null | 250032254 | GEMCITABINE + PACLITAXEL |
| 250007514 | 250005260 | 1.83 | 67.7 | Curative (C) | 2017-10-08 | 2017-10-10 | ANAGRELIDE | N | N | 250032254 | RUXOLITINIB |
| 250007515 | 250005261 | null | null | null | 2016-03-03 | 2016-03-17 | Rituximab | N | null | 250032257 | RUXOLITINIB |
| 250007516 | 250009756 | 1.53 | 77 | Curative (C) | 2016-01-05 | 2016-01-05 | Azacitidine | 2 | N | 250032258 | RUXOLITINIB |
| 250007519 | 250005263 | null | null | Adjuvant (A) | null | 2014-10-08 | CHOP R | N | N | 250032261 | CYTARABINE |
| 250007520 | 250005263 | null | 78.1 | Disease modification (D) | 2013-04-23 | 2013-04-23 | ANAGRELIDE + Hydroxycarbamide | 2 | N | 250032261 | LENALIDOMIDE |
| 250007522 | 250005265 | 1.74 | 102.1 | Palliative (P) | 2017-01-25 | 2017-02-23 | RUXOLITINIB | N | N | 250032268 | BENDAMUSTINE + RITUXIMAB |
| 250007523 | 250005265 | 0 | 61.3 | Palliative (P) | 2015-10-17 | 2015-10-26 | RUXOLITINIB | N | N | 250032268 | RUXOLITINIB |
| 250007524 | 250005265 | 1.85 | 68 | Disease modification (D) | null | 2014-03-03 | RUXOLITINIB | N | N | 250032268 | INTERFERON |
| 250007525 | 250005265 | null | null | null | 2016-09-07 | 2016-09-20 | RUXOLITINIB | N | N | 250032268 | BUSULPHAN |
| 250007526 | 250005266 | 1.67 | 60.3 | Palliative (P) | 2013-09-06 | 2013-09-06 | RUXOLITINIB | N | N | 250032279 | BUSULPHAN |
| 250007527 | 250005267 | null | null | Palliative (P) | 2017-11-03 | 2017-11-04 | PEMBROLIZUMAB | N | N | 250032282 | CHLORAMBUCIL + RITUXIMAB |
| 250007528 | 250005268 | null | 0 | Palliative (P) | 2014-11-11 | 2014-11-19 | null | N | N | 250032283 | ANAGRELIDE |
| 250007529 | 250005269 | null | 55.9 | null | 2017-02-02 | 2017-02-02 | RUXOLITINIB | N | null | 250032287 | ANAGRELIDE |
| 250007530 | 250005270 | null | 74 | Palliative (P) | 2014-05-20 | 2014-05-20 | RUXOLITINIB | Y | N | 250032293 | RITUXIMAB |
| 250007531 | 250005271 | 1.78 | null | Disease modification (D) | 2013-08-12 | 2013-09-12 | CVP R | N | N | 250032297 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |